source: pixabay.com

CPRIT Awards Emtora Biosciences $3 Million Grant to Develop Investigational Familial Adenomatous Polyposis Drug

Post author:Scott Carlson
Post published:September 3, 2019
Post category:Attenuated familial adenomatous polyposis Familial Adenomatous Polyposis

According to a recent press release, Texas-based biotechnology company Emtora Biosciences was chosen earlier this month to receive a $3 million grant from the Cancer Prevention and Research Institute of…

WHATNEXT.com

Patient Worthy is excited to announce our partnership with WHATNEXT, an oncology focused website that helps people find reliable answers to questions about their disease, find support, and find life beyond cancer

Connect

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

WHATNEXT.com

CPRIT Awards Emtora Biosciences $3 Million Grant to Develop Investigational Familial Adenomatous Polyposis Drug

Metastatic Breast Cancer: Navigating Grief

Rethinking What It Means to Live With Acromegaly

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

WHATNEXT.com

Let’s Work Together!

Keep Up to Date

Learn More